Largest Insider Buys of the Week

Author's Avatar
May 23, 2014
Article's Main Image

Over the past week there were several companies reporting smaller insider buys along some large insider sells. The following insiders reported the largest insider buys over the past week. These transactions were judged based on the number of insiders buying, transaction amount and the amount of shares being purchased

Atlas Resource Partners (ARP)

Over the past week there were two insiders making buys in Atlas Resource Partners. These two insiders added a combined 60,000 shares to their holdings as the price has fallen to a 52-week low.

Chairman and CEO Edward Cohen added 40,000 shares to his holdings on May 19. The CEO bought these shares at $19.83 per share. This transaction cost him $793,200, and since then the price per share has increased a slight 0.25%. Cohen now holds on to at least 499,743 shares of the company’s stock.

Vice Chairman Jonathan Cohen increased his holdings by a smaller 20,000 shares. Cohen bought these shares for $19.74 for a total transaction amount of $394,800. The Chairman now holds on to at least 541,851 shares, and since his most recent buy the price per share is trading up approximately 0.71%

03May20171429381493839778.png

As seen in the graph above, the company has maintained consistent insider buys since its inception in early 2012.

Atlas Resource Partners LP is a publicly-traded master-limited partnership and a developer and producer of natural gas, crude oil and natural gas liquids, with operations in basins across the United States.

Atlas Resource Partners’ historical revenue and net income:

03May20171429381493839778.png

The analysis on Atlas Resource Partners reports that the company has issued $876.4 million in debt over the past three years, the company’s dividend yield is near a 1-year high and its price is near a 3-year low.

The company recently announced that it completed its acquisition of long-lived, shallow decline natural gas production in West Virginia and Virginia from GeoMet for $107 million.

Atlas Resource Partners LP has a market cap of $1.3 billion. Its shares are currently trading at around $19.80 with a P/S ratio of 2.20. The dividend yield of Atlas Resource Partners is at 11.40%.

Magellan Health Services (MGLN)

Over the past week there were two insiders making pretty significant buys into the company’s stock. These two insiders added a combined 20,000 shares.

CEO Barry Smith added 10,000 shares to his holdings on May 19. He bought these shares at $58.56 per share for a total transaction amount of $585,600. Since then the price per share has increased approximately 0.53%. Smith now holds on to 23,427 shares of the company’s stock.

Director Robert LeBlanc also added 10,000 shares to his stake. The director bought these on May 14 at $55.60 per share for a total transaction amount of $556,000. Since his buy the price per share has increased approximately 5.88%. LeBlanc now holds on to at least 29,939 shares of the company’s stock.

03May20171429391493839779.png

Magellan Health Services provides specialty healthcare services. The Company's business is divided into six segments, based on the services it provides and/or the customers that it serves.

Magellan’s historical revenue and net income:

03May20171429391493839779.png

The analysis on Magellan Health Services reports that the company’s price is near a 10-year high, the company holds enough cash to cover all of its debt, and the company’s P/B and P/S ratios are trading at historic lows.

The Peter Lynch Chart suggests that the company is currently overvalued:

03May20171429391493839779.png

Magellan Health Services has a market cap of $1.67 billion. Its shares are currently trading at around $60.49 with a P/E ratio of 13.60 and a P/S ratio of 0.50. The company had an annual average earnings growth of 4.90%.

You can check out more insider buys by looking at the GuruFocus Insider Page. Or for more specific information, you can check out the GuruFocus All-in-One Screener under the Insider tab.

Try a free 7-day premium membership trial here.